Lawyers No Longer Reviewing Lipitor Diabetes Lawsuits

The Lipitor lawyers at Saiontz & Kirk, P.A. are no longer accepting potential product liability lawsuits for users of the popular cholesterol drug who have been diagnosed with diabetes. This page is maintained for informational purposes only.

Studies have found that side effects of Lipitor may increase the risk of diabetes and other serious health complications associated with the disease, especially among otherwise health women prescribed the cholesterol drug.

Although it appears that the manufacturer knew or should have known about the risk of health problems from Lipitor, inadequate warnings were provided for users and the medical community.

Thousands of Lipitor diabetes lawsuit have been filed by women nationwide. However, in January 2017, the federal judge presiding over the litigation granted a motion for summary judgment, dismissing all cases. This decision has been upheld on appeal and new claims are no longer being reviewed for women who developed diabetes. The content on this page outlines the basis for these prior claims.

Lipitor Diabetes Problems

Lipitor (atorvastatin) was introduced in 1996 by Warner-Lambert Company, which was subsequently acquired by Pfizer.

Amid agressive marketing and promotion, the cholesterol drug became one of the top selling brand name drugs in the world, generating more than $125 billion in sales before generic Lipitor became available in 2011.

Lipitor is a member of a class of drugs known as “statins”, which work by preventing the liver from creating an enzyme that helps the body produce cholesterol. This helps the body reduce the levels of low-density lipoprotein (LDL) cholesterol, often referred to as “bad cholesterol.”

Statins have been linked to a number of serious health problems and side effects, including muscle injury, kidney problems, and diabetes.

In 2012, the FDA forced label changes for Lipitor and other statins to add information to the “Warnings and Precautions” section about the potential link to an increased risk of diabetes.

However, lawsuits alleged that the Lipitor warnings added by Pfizer remained incomplete and inadequate, failing to properly warn users or the medical community about the risk of diabetes or the importance of monitoring blood glucose levels. As a result, thousands of women may have developed diabetes from Lipitor that could have been avoided if more accurate information had been provided about the risk.

Allegations Raised in Lipitor Lawsuits

Some of the common allegations raised in Lipitor diabetes lawsuits include:

  • Pfizer knew or should have known that Lipitor causes type 2 diabetes and may increase blood glucose levels, yet continued to market the medication as safe and effective
  • Lipitor is defective and unsafe because it is not accompanied by proper warnings about the potential side effects of developing diabetes
  • Drug makers have a duty to properly research medications and provide proper warnings to inform users and the medical community about unreasonable and dangerous risks
  • Pfizer failed to perform appropriate studies of Lipitor before it was introduced or conduct adequate surveillance of Lipitor problems reported by users after it was sold
  • Pfizer was overly aggressive and deceitful in marketing and promoting the use of Lipitor, resulting in billions of dollars in annual sales revenue
  • If proper warnings were provided, individuals may have avoided the risk of diabetes by deciding not to use Lipitor or by closely monitoring blood glucose levels to see if the drug was adversely affecting their metabolism

Lipitor Class Action Lawyers

The attorneys at Saiontz & Kirk, P.A. are no longer reviewing potential for Lipitor class action lawsuits or individual injury claims on behalf of women diagnosed with diabetes. This page is maintained for informational purposes only.